Entero Healthcare Solutions Share Price Today | Stock Price & Entero Healthcare Solutions Share Screener
As of November 19, 2026, the live Entero Healthcare Solutions share price (NSE: ENTERO) is ₹1,973.00 on NSE and ₹1,977.30 on BSE, down 0.65% from the previous close, with shares trading between ₹1,940.00 and ₹2,000.00 in today's trading session, and a 52-week range of ₹949.20–₹2,114.90. Track ENTERO market cap trends to gauge the company's total market size. Use the Entero Healthcare Solutions stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Entero Healthcare Solutions opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹2,091 and net income of ₹61, with EBITDA of ₹115, an operating margin of 5.0% and a profit margin of 2.9%.
Entero Healthcare Solutions Share Price Chart
Track the current stock price of Entero Healthcare Solutions with an interactive chart. Analyse ENTERO share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Entero Healthcare Solutions stock quote in one place.
The quote of ₹1,973.00 sits between the 52-week low of ₹949.20 and the 52-week high of ₹2,114.90, and the latest session moved -0.65% from the previous close.
Entero Healthcare Solutions Company Profile - Fundamental Screener
Screen Entero Healthcare Solutions company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ENTERO shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Consumer Services sector and the Retail industry, and it trades under ISIN INE010601016.
Company Details
Classification
Identifiers and Leadership
Entero Healthcare Solutions Balance Sheet Screener
Screen ENTERO balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹3,600, up from ₹2,703 in 2025.
Latest statistics put total assets at ₹3,600 and shareholder funds at ₹1,753, with a leverage ratio of 0.31.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
Assets |
|||||||
| Total Assets | 3,600 | 2,703 | 2,345 | 1,309 | 1,126 | 836 | 749 |
| Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fixed Assets | 958 | 559 | 289 | 268 | 262 | 189 | 186 |
Liabilities |
|||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 260 | 87 | 102 | 87 | 101 | 58 | 56 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
|||||||
| Total Equity | 1,753 | 1,770 | 1,641 | 598 | 563 | 487 | 424 |
| Share Capital | 44 | 44 | 44 | 4 | 4 | 517 | 439 |
| Reserves & Surplus | 1,639 | 1,676 | 1,593 | -73 | -62 | -32 | -16 |
Entero Healthcare Solutions Income Statement Screener - Profit & Revenue Analysis
Screen Entero Healthcare Solutions income statement and profit fundamentals. Analyze ENTERO quarterly results. Entero Healthcare Solutions reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For 2026-Sept, revenue was ₹2,091 and net profit was ₹61, equal to earnings per unit of ₹10.47, at an operating margin of 5%.
In that period expenses were ₹1,976, interest cost ₹23 and tax ₹18. The next period listed, 2026-Jun, shows revenue of ₹1,944 and net profit of ₹52.
| Item | 2026-Sept | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||||||||||
| Revenue | 2,091 | 1,944 | 1,914 | 1,711 | 1,576 | 1,410 | 1,346 | 1,367 | 1,312 | 1,111 | 1,043 | 994 | 998 | 901 | 888 |
| Expenses | 1,976 | 1,844 | 1,824 | 1,647 | 1,509 | 1,354 | 1,290 | 1,309 | 1,258 | 1,067 | 1,005 | 964 | 968 | 873 | 867 |
Operating Costs and Margins | |||||||||||||||
| EBITDA | 115 | 100 | 90 | 64 | 67 | 56 | 56 | 58 | 54 | 44 | 38 | 30 | 31 | 27 | 21 |
| Operating Profit % | 5.00% | 5.00% | 5.00% | 3.00% | 4.00% | 4.00% | 4.00% | 4.00% | 3.00% | 3.00% | 3.00% | 3.00% | 3.00% | 3.00% | 2.00% |
| Depreciation | 13 | 12 | 15 | 10 | 10 | 9 | 9 | 8 | 8 | 7 | 7 | 6 | 6 | 6 | 7 |
| Interest | 23 | 21 | 17 | 14 | 12 | 11 | 11 | 10 | 12 | 10 | 17 | 16 | 18 | 14 | 13 |
Profit and Earnings | |||||||||||||||
| Profit Before Tax | 78 | 67 | 58 | 40 | 45 | 36 | 37 | 39 | 35 | 27 | 14 | 8 | 7 | 7 | 1 |
| Tax | 18 | 15 | 13 | 7 | 8 | 6 | 6 | 10 | 9 | 7 | -8 | 1 | 2 | 0 | 5 |
| Net Profit | 61 | 52 | 45 | 34 | 37 | 30 | 31 | 30 | 26 | 21 | 21 | 7 | 5 | 6 | -4 |
| EPS | 10.47 | 8.77 | 6.44 | 6.35 | 7.26 | 6.39 | 5.91 | 5.85 | 5.43 | 4.62 | 5.73 | 4.21 | 3.24 | 15.18 | 1.49 |
Entero Healthcare Solutions Cash Flow Screener - Liquidity Fundamentals
Screen ENTERO cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities generated ₹96, and net cash flow was an outflow of ₹82.
Over the same period, investing activities used ₹302 and financing activities provided ₹124.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March |
|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | |||||||
| Operating Activities | 96 | -77 | -37 | -45 | -35 | -69 | -37 |
| Investing Activities | -302 | 232 | -704 | -49 | -162 | -31 | -203 |
Financing and Net Cash | |||||||
| Financing Activities | 124 | -74 | 863 | 73 | 211 | 89 | 217 |
| Net Cash Flow | -82 | 82 | 122 | -21 | 14 | -11 | -23 |
Entero Healthcare Solutions Shareholding Pattern Screener
See Entero Healthcare Solutions shareholding pattern with promoter, FII, and DII holdings. Check Entero Healthcare Solutions promoter holding and ownership changes for ENTERO on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 52.42%, foreign institutions 4.03%, domestic institutions 16.62% and the public 12.25%, spread across 39,084 shareholders.
The shareholder count was 39,084 in 2026-Mar, compared with 39,710 in 2026-Jun.
| Item | 2026-Mar | 2026-Jun | 2026-Sept | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Feb |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 52.42% | 52.40% | 52.40% | 52.42% | 52.42% | 52.42% | 52.42% | 52.44% |
Institutional Investors | ||||||||
| FII Holding | 4.03% | 4.37% | 5.77% | 19.92% | 17.20% | 14.67% | 5.14% | 0.00% |
| DII Holding | 16.62% | 15.48% | 21.16% | 9.64% | 10.18% | 9.65% | 16.42% | 1.36% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 12.25% | 13.05% | 13.14% | 5.41% | 6.99% | 9.36% | 11.56% | 5.72% |
| Other Holding | 14.68% | 14.70% | 7.53% | 12.61% | 13.20% | 13.90% | 14.46% | 40.48% |
| Shareholder Count | 39,084 | 39,710 | 40,919 | 33,159 | 33,338 | 36,334 | 40,333 | 58 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Entero Healthcare Solutions. Entero Healthcare Solutions dividend yield can be compared with peers and other stocks in the market.
Entero Healthcare Solutions Stock Index Membership - Nifty & Sensex
See which indices include Entero Healthcare Solutions stock. Check ENTERO index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
The company is listed in 6 indices, including BSE 1000.
Among the benchmarks tracked are BSE 1000, BSE Consumer Discretionary Index, BSE INDEX SMLCAP, NIFTY IPO.
Complete Index List
Entero Healthcare Solutions Market Events Screener - Corporate Actions
Get Entero Healthcare Solutions corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Entero Healthcare Solutions stock events that may affect ENTERO share price, along with derivatives, futures and options activity and sector gainers.
12 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 4, 2026, with a record date of November 4, 2026.
It is followed by Annual General Meeting dated August 19, 2026 and Quarterly Result Announcement dated August 7, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-11-04 | 2026-11-04 | Quarterly Result Announcement | NA | 6.85% |
| 2026-08-19 | 2026-08-19 | Annual General Meeting | NA | 3.97% |
| 2026-08-07 | 2026-08-07 | Quarterly Result Announcement | NA | -2.43% |
| 2026-05-25 | 2026-05-25 | Quarterly Result Announcement | NA | 13.55% |
| 2026-02-12 | 2026-02-12 | Quarterly Result Announcement | NA | 1.49% |
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | -2.01% |
| 2025-09-18 | 2025-09-18 | Annual General Meeting | NA | -2.28% |
| 2025-08-08 | 2025-08-08 | Quarterly Result Announcement | NA | -0.69% |
| 2025-05-27 | 2025-05-27 | Quarterly Result Announcement | NA | 2.33% |
| 2025-02-12 | 2025-02-12 | Quarterly Result Announcement | NA | -3.18% |
| 2024-11-12 | 2024-11-12 | Quarterly Result Announcement | NA | 6.49% |
| 2024-08-28 | 2024-08-28 | Annual General Meeting | NA | 4.51% |
Entero Healthcare Solutions Competitors Screener - Peer Stocks Comparison
Screen ENTERO competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Consumer Services sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Eternal | 361,936 | 727.20 | 55,760 | 161.54% | 366 | 72.55 |
| Avenue Supermarts DMart | 226,329 | 72.30 | 68,895 | 15.82% | 2,970 | 55.55 |
| Trent | 169,377 | 89.30 | 20,189 | 16.34% | 1,721 | 64.34 |
| Lenskart Solutions | 128,543 | 160.40 | 8,988 | 28.23% | 501 | 67.22 |
| Meesho | 116,877 | -126.20 | 13,099 | 32.30% | -1,358 | 66.69 |
| Nykaa | 102,542 | 316.20 | 10,055 | 26.05% | 204 | 57.75 |
| Info Edge | 76,189 | 34.20 | 4,343 | 10.72% | 1,763 | 43.03 |
| Swiggy | 52,032 | -14.70 | 23,561 | 50.81% | -4,154 | 38.88 |
| Vishal Mega Mart | 43,564 | 49.30 | 12,993 | 20.58% | 839 | 47.18 |
| Urban Company | 24,926 | -58.00 | 1,692 | 34.23% | -235 | 52.83 |
Entero Healthcare Solutions Company Announcements - News & Reports Screener
Screen ENTERO latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated November 15, 2026.
The next most recent announcements are dated November 6, 2026 and November 5, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-11-15 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-11-06 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-11-05 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-11-05 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-11-05 | Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 | - |
| 2026-11-04 | Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. | - |
| 2026-11-04 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-11-04 | Grant Of Fresh 49712 (Forty-Nine Thousand Seven Hundred Twelve) Employee Stock Options Under The Existing Entero Employee Stock Option Plan 2023. | - |
| 2026-11-04 | Unaudited Financial Results Of The Company For The Quarter And Half Year Ended September 30 2026 | - |
| 2026-11-04 | Board Meeting Outcome for Outcome Of Board Meeting Held On November 04 2026 | - |
| 2026-10-28 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-10-22 | Board Meeting Intimation for Consider Approve And Take On Record The Unaudited Standalone And Consolidated Financial Results (Along With Limited Review Report) For The Quarter Ended September 30 2026 | - |
| 2026-10-13 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-10-12 | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | - |
| 2026-09-23 | Closure of Trading Window | - |
| 2026-09-22 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-09-22 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-09-12 | Entero Healthcare Solutions Limited Has Informed The Exchange About General Updates | - |
| 2026-08-26 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-08-24 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹1,973.00, within a 52-week range of ₹949.20 to ₹2,114.90. The P/E ratio is 44.70 and the P/B ratio is 4.81, with earnings per unit of ₹26.44. Market capitalisation stands at ₹8,559.25 Cr. The company operates in the Consumer Services sector, in the Retail industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the NSE and the BSE. Key statistics were last updated on November 20, 2026. This page covers 7 balance sheet periods, 15 income statement periods, 7 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.